Technical Analysis for CEMI - Chembio Diagnostics, Inc.

Grade Last Price % Change Price Change
F 5.56 -1.59% -0.09
CEMI closed down 1.59 percent on Friday, February 26, 2021, on 66 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
Earnings due: Mar 11
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical CEMI trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
200 DMA Resistance Bearish -1.59%
NR7 Range Contraction -1.59%
Lower Bollinger Band Walk Weakness -1.59%
Wide Bands Range Expansion -1.59%
Oversold Stochastic Weakness -1.59%
200 DMA Resistance Bearish -3.89%
Bullish Engulfing Bullish -3.89%
Older End-of-Day Signals for CEMI ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% 2 days ago
Down 3% 2 days ago
Down 2 % 2 days ago
Down 1% 2 days ago
Fell Below Previous Day's Low 2 days ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Chembio Diagnostics, Inc. Description

Chembio Diagnostics, Inc., together with its wholly-owned subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care diagnostic tests that detect infectious diseases. It offers rapid tests for the detection of HIV antibodies, syphilis, and canine leishmaniasis. Its products include lateral flow rapid HIV tests and Dual Path Platform (DPP) HIV Test, which detect antibodies to HIV 1 and 2 with visually interpreted results; a multiplex Syphilis Screen and Confirm test, a multiplex test for the separate detection of antibodies to HIV and Syphilis; and a rapid test for the detection of Hepatitis-C antibodies and antigens. The company sells its products under its STAT PAK, SURE CHECK, or DPP trademarks, as well as under the private labels of its marketing partners. Chembio Diagnostics, Inc. sells its products to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. The company has collaboration agreements with the Oswaldo Cruz Foundation relating to products based on its DPP technology products. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Medford, New York.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Immunology Immune System Infectious Diseases Antibodies Technology Products Antibody Multiplex Medical Tests Diagnostic Tests Public Health HIV HIV/Aids Ortho Clinical Diagnostics Retail Establishments Diagnosis Of Hiv/Aids Diagnostic Systems Medford

Is CEMI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 15.89
52 Week Low 2.25
Average Volume 991,689
200-Day Moving Average 5.74
50-Day Moving Average 6.06
20-Day Moving Average 6.81
10-Day Moving Average 6.19
Average True Range 0.55
ADX 36.98
+DI 19.91
-DI 28.17
Chandelier Exit (Long, 3 ATRs ) 6.71
Chandelier Exit (Short, 3 ATRs ) 6.56
Upper Bollinger Band 8.48
Lower Bollinger Band 5.14
Percent B (%b) 0.12
BandWidth 48.96
MACD Line -0.19
MACD Signal Line 0.06
MACD Histogram -0.2511
Fundamentals Value
Market Cap 112.18 Million
Num Shares 20.2 Million
EPS -0.73
Price-to-Earnings (P/E) Ratio -7.62
Price-to-Sales 3.36
Price-to-Book 3.17
PEG Ratio -0.48
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.22
Resistance 3 (R3) 6.22 6.00 6.11
Resistance 2 (R2) 6.00 5.83 6.00 6.07
Resistance 1 (R1) 5.78 5.73 5.67 5.78 6.04
Pivot Point 5.56 5.56 5.51 5.56 5.56
Support 1 (S1) 5.34 5.39 5.23 5.34 5.08
Support 2 (S2) 5.12 5.29 5.12 5.05
Support 3 (S3) 4.90 5.12 5.01
Support 4 (S4) 4.90